Gliadin sequestration as a novel therapy for celiac disease: A prospective application for polyphenols

19Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

Abstract

Celiac disease is an autoimmune disorder characterized by a heightened immune response to gluten proteins in the diet, leading to gastrointestinal symptoms and mucosal damage localized to the small intestine. Despite its prevalence, the only treatment currently available for celiac disease is complete avoidance of gluten proteins in the diet. Ongoing clinical trials have focused on targeting the immune response or gluten proteins through methods such as immunosuppression, enhanced protein degradation and protein sequestration. Recent studies suggest that polyphenols may elicit protective effects within the celiac disease milieu by disrupting the enzymatic hydrolysis of gluten proteins, sequestering gluten proteins from recognition by critical receptors in pathogenesis and exerting anti-inflammatory effects on the system as a whole. This review highlights mechanisms by which polyphenols can protect against celiac disease, takes a critical look at recent works and outlines future applications for this potential treatment method.

Cite

CITATION STYLE

APA

Van Buiten, C. B., & Elias, R. J. (2021, January 2). Gliadin sequestration as a novel therapy for celiac disease: A prospective application for polyphenols. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms22020595

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free